BSP, particularly when evaluated alongside other biomarkers such as hormone receptors or prostate-specific antigen (PSA), holds potential to facilitate early cancer detection, guide treatment strategies and provide valuable insights into treatment response and disease progression. The gene discussed is IBSP; the disease is cancer.